CLINICAL_TRIALS
trial_result
· 2019-09-03
Clinical Trial Update: Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes [Phase 4]
Summary
A Phase 4 clinical trial evaluating the effect of dapagliflozin on nighttime blood pressure in individuals with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LM Diagnósticos S.L. | Conditions: Type2 Diabetes | Phase 4 | Status: UNKNOWN